Altered T Cell Responses in Myalgic Enchephalomeylitis/Chronic Fatigue Syndrome (ME/CFS)

肌痛性脑脊髓炎/慢性疲劳综合征 (ME/CFS) 中 T 细胞反应的改变

基本信息

项目摘要

Project Summary/Abstract Myalgic enchephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disorder affecting numerous organ systems and biological processes. Published data seems to suggest that ME/CFS may be preceded by infection, and the chronic manifestation of illness may represent an altered host response to infection, or an inability to resolve inflammation. Previous studies focused on perturbation in cytokines and metabolism have also shown that CD8 T responses are decreased in ME/CFS. In preliminary studies we examined the frequency, functional and phenotypic status of CD8 T cells to determine whether they were altered in chronic ME/CFS donors as compared to healthy donors. We observed an increased CD4:CD8 ratio, altered expression of exhaustion/activation markers like CTLA4 and 2B4 on CD8 T cells, and decreased production of IFN, TNF and CD107a/b upregulation following PMA stimulation, all suggesting CD8 T cell exhaustion. This was associated with a, perhaps compensatory increased frequency of activated CD4+CD8+ T cells in the ME/CFS donors as compared to healthy controls. Notably, a subset of the CD8 and the CD4+CD8+ T cell populations were spontaneously producing atypical cytokines, subdividing ME/CFS donors into two subsets: type 1 had an increased frequency of FoxP3+helios+ Treg-like cells producing IL9 (female donors); type 2 had FoxP3+helios- cells producing IL17 (male donors). When we examined the T-cell receptor (TCR) repertoire of the CD4+CD8+ T cell population we found evidence of antigen driven clonal expansions to an unknown antigen at this time, whether it will be a viral or auto-antigen. We hypothesize that the common theme in ME/CFS is an aberrant response to an immunological trigger like infection, which results in a permanently dysregulated immune system as a result of CD8 T cell exhaustion. These studies will identify potential biomarkers and mechanisms driving the immunopathogenesis of ME/CFS leading to future therapies. We will explore this hypothesis in the following Aims. Aim 1 we will examine altered CD8 and CD4+CD8+ T-cell responses in ME/CFS: 1) we will determine if the level of CD8 T cell exhaustion varies with ME/CFS type 1 (female) and Type 2 (male) response and with the severity of ME/CFS symptoms using a larger ME/CFS cohort; 2) we will examine EBV antigen-specific responses in ME/CFS donors to determine if a common persistent virus response is altered by the immunosuppressive state of CD8 T cell exhaustion and further contributing to the disease state of ME/CFS; 3) microarray analyses will be done on sorted activated T cell subsets to assist in understanding the alterations in the functionality of the exhausted and activated CD8 and CD4+CD8+ T cell subsets in ME/CFS donors. In Aim 2 we will examine TCR repertoire of CD8 and CD4+CD8+ T-cell subsets for evidence of antigen driven clonal expansion. Defining the characteristics of the activated clonally expanded CD8 and CD4+CD8+ T cells would be a major step in the field potentially leading to the identification a specific infectious or auto-antigen response that could be the main driver of CD8 T cell exhaustion and the immunological basis of ME/CFS.
项目摘要/摘要 肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)是一种累及多个器官的复杂疾病 系统和生物过程。已发表的数据似乎表明,ME/CFS可能先于感染, 疾病的慢性表现可能代表宿主对感染的反应改变,或者无法 消炎消炎。以前的研究集中在细胞因子和新陈代谢的扰动上,也表明 ME/CFS患者CD8T反应降低。在初步研究中,我们检查了频率、功能 和CD8T细胞的表型状态,以确定其在慢性ME/CFS供者中是否发生了改变 与健康的捐赠者相比。我们观察到CD4:CD8比率增加,表达改变 CD8T细胞表面CTLA4和2B4等耗竭/激活标志物以及干扰素、肿瘤坏死因子的产生减少 PMA刺激后CD107a/b表达上调,均提示CD8T细胞耗竭。这是 与ME/CFS中活化的CD4+CD8+T细胞的频率可能代偿性增加有关 捐献者与健康对照相比。值得注意的是,CD8和CD4+CD8+T细胞亚群 自发产生非典型细胞因子,将ME/CFS捐赠者细分为两个子集:类型1具有 FoxP3+Helios+Treg样细胞产生IL9的频率增加;2型FoxP3+Helios- 产生IL17(男性供体)的细胞。当我们检测了CD4+CD8+T细胞的T细胞受体(TCR)谱系时 细胞群我们发现了抗原驱动的克隆扩张到未知抗原的证据, 无论它是病毒还是自身抗原。我们假设ME/CFS的共同主题是反常的 对免疫触发的反应,如感染,导致永久性免疫系统失调 由于CD8 T细胞耗尽所致。这些研究将确定潜在的生物标志物和驱动机制 ME/CFS的免疫发病机制导致未来的治疗。我们将在以下内容中探讨这一假设 目标。目的1)我们将检测ME/CFs中改变的CD8和CD4+CD8+T细胞反应:1)我们将确定 CD8 T细胞耗竭水平随ME/CFS 1型(女性)和2型(男性)的反应以及 使用更大的ME/CFS队列研究ME/CFS症状的严重性;2)我们将检查EBV抗原特异性反应 在ME/CFS供体中确定免疫抑制是否改变了常见的持久性病毒反应 CD8 T细胞耗竭状态及其与ME/CFS疾病状态的关系;3)基因芯片分析 将在已排序的激活T细胞亚群上完成,以帮助了解 ME/CFS供者CD8和CD4+CD8+T细胞亚群的耗竭和激活。在目标2中,我们将研究TCR CD8和CD4+CD8+T细胞亚群,以寻找抗原驱动的克隆性增殖的证据。定义 活化的克隆性扩增的CD8和CD4+CD8+T细胞的特性将是该领域的重要一步 可能导致确定一种可能是主要驱动力的特定的感染性或自身抗原反应 CD8T细胞耗竭和ME/CFS的免疫学基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Liisa Kaarina Selin其他文献

Liisa Kaarina Selin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Liisa Kaarina Selin', 18)}}的其他基金

Altered T Cell Responses in Myalgic Enchephalomeylitis/Chronic Fatigue Syndrome (ME/CFS)
肌痛性脑脊髓炎/慢性疲劳综合征 (ME/CFS) 中 T 细胞反应的改变
  • 批准号:
    10368149
  • 财政年份:
    2021
  • 资助金额:
    $ 48.89万
  • 项目类别:
Altered T Cell Responses in Myalgic Enchephalomeylitis/Chronic Fatigue Syndrome (ME/CFS)
肌痛性脑脊髓炎/慢性疲劳综合征 (ME/CFS) 中 T 细胞反应的改变
  • 批准号:
    10185392
  • 财政年份:
    2021
  • 资助金额:
    $ 48.89万
  • 项目类别:
EBV and Heterologous Alloimmunity in Humanized Mice
人源化小鼠中的 EBV 和异源同种免疫
  • 批准号:
    8279394
  • 财政年份:
    2011
  • 资助金额:
    $ 48.89万
  • 项目类别:
EBV and Heterologous Alloimmunity in Humanized Mice
人源化小鼠中的 EBV 和异源同种免疫
  • 批准号:
    7994924
  • 财政年份:
    2010
  • 资助金额:
    $ 48.89万
  • 项目类别:
Crossreactivity of T Cells in Human Virus Infections
人类病毒感染中 T 细胞的交叉反应
  • 批准号:
    7099390
  • 财政年份:
    2006
  • 资助金额:
    $ 48.89万
  • 项目类别:
Crossreactivity of T Cells In Human Virus Infections
人类病毒感染中 T 细胞的交叉反应
  • 批准号:
    8367072
  • 财政年份:
    2001
  • 资助金额:
    $ 48.89万
  • 项目类别:
IMMUNITY IN SYSTEMIC AND MUCOSAL VIRUS INFECTIONS
全身和粘膜病毒感染的免疫力
  • 批准号:
    6193249
  • 财政年份:
    2000
  • 资助金额:
    $ 48.89万
  • 项目类别:
IMMUNITY IN SYSTEMIC AND MUCOSAL VIRUS INFECTIONS
全身和粘膜病毒感染的免疫力
  • 批准号:
    6374380
  • 财政年份:
    2000
  • 资助金额:
    $ 48.89万
  • 项目类别:
IMMUNITY IN SYSTEMIC AND MUCOSAL VIRUS INFECTIONS
全身和粘膜病毒感染的免疫力
  • 批准号:
    6511171
  • 财政年份:
    2000
  • 资助金额:
    $ 48.89万
  • 项目类别:
IMMUNITY IN SYSTEMIC AND MUCOSAL VIRUS INFECTIONS
全身和粘膜病毒感染的免疫力
  • 批准号:
    6632193
  • 财政年份:
    2000
  • 资助金额:
    $ 48.89万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.89万
  • 项目类别:
    Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 48.89万
  • 项目类别:
    Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 48.89万
  • 项目类别:
    Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 48.89万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 48.89万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 48.89万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 48.89万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 48.89万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 48.89万
  • 项目类别:
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 48.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了